<DOC>
	<DOCNO>NCT00742430</DOCNO>
	<brief_summary>The purpose study determine whether aspirin clopidogrel resistance measure Multiplate function analyser good correlation incidence major adverse cardiac event patient coronary artery disease ( CAD ) .</brief_summary>
	<brief_title>Resistance Antithrombotic Drugs Ischemic Heart Disease</brief_title>
	<detailed_description>Our plan enroll 180 patient diagnosed CAD electively undergo percutaneous coronary intervention ( PCI ) . Blood sample take procedure one day procedure analyse Multiplate function analyser . Assessing aspirin clopidogrel resistance incidence use Multiplate platelet function analyzer also try find resistance correlation incidence major adverse cardiac event one year follow .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Elective PCI &gt; 7 day aspirin 100mg therapy intervention &gt; 7 day clopidogrel 75mg therapy intervention Loading dose clopidogrel &lt; 7 day aspirin therapy intervention Myocardial infarction le 30 day intervention Cerebrovascular incident less three month intervention Haemorrhagic diathesis Trc &lt; 100 Htc &lt; 30 % Creatinine &gt; 140</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>aspirin resistance</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>clopidogrel resistance</keyword>
	<keyword>major adverse cardiac event</keyword>
	<keyword>multiplate platelet function analyser</keyword>
	<keyword>percutaneous coronary intervention</keyword>
</DOC>